EGF and neoplasm: The ability of exosome surface-expressing ligands or receptors like those for growth factors like epidermal growth factor (EGF) to target EGF-R-expressing tumor cells [252], as well as enzymes [253], and inhibitors like TGFβ–1 [254] enables them to target cancer cells.